A critical review of in vitro dosimetry for engineered nanomaterials.
A major obstacle in the development of accurate cellular models for investigating nanobio interactions in vitro is determination of physiologically relevant measures of dose. Comparison of biological responses to nanoparticle exposure typically relies on administered dose metrics such as mass concentration of suspended particles, rather than the effective dose of particles that actually comes in contact with the cells over the time of exposure. Adoption of recently developed dosimetric methodologies will facilitate determination of effective dose delivered to cells in vitro, thereby improving the accuracy and reliability of in vitro screening data, validation of in vitro with in vivo data, and comparison across multiple datasets for the large variety of nanomaterials currently in the market.